170 related articles for article (PubMed ID: 32266577)
1. Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea.
Jeon SM; Park S; Kim D; Kwon JW
Eur Child Adolesc Psychiatry; 2021 Mar; 30(3):391-399. PubMed ID: 32266577
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.
Bloechliger M; Rüegg S; Jick SS; Meier CR; Bodmer M
CNS Drugs; 2015 Jul; 29(7):591-603. PubMed ID: 26242478
[TBL] [Abstract][Full Text] [Related]
3. Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case-control study.
Lee H; Song DH; Kwon JW; Han E; Chang MJ; Kang HY
Eur Child Adolesc Psychiatry; 2018 Oct; 27(10):1321-1334. PubMed ID: 29460164
[TBL] [Abstract][Full Text] [Related]
4. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
5. Association of Treatment With Antipsychotics, Antidepressants, or Both With Movement Disorders and Seizures Among Children and Adolescents With Depression in Korea.
Jeon SM; Park HY; Park S; Chung US; Kwon JW
JAMA Netw Open; 2022 Apr; 5(4):e227074. PubMed ID: 35426925
[TBL] [Abstract][Full Text] [Related]
6. Comparative cardiometabolic risk of antipsychotics in children, adolescents and young adults.
Chung YS; Shao SC; Chi MH; Lin SJ; Su CC; Kao Yang YH; Yang YK; Lai EC
Eur Child Adolesc Psychiatry; 2021 May; 30(5):769-783. PubMed ID: 32472205
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
8. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
10. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Somnolence effects of antipsychotic medications and the risk of unintentional injury.
Said Q; Gutterman EM; Kim MS; Firth SD; Whitehead R; Brixner D
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):354-64. PubMed ID: 18314925
[TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia following treatment with antipsychotic medications.
Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
[TBL] [Abstract][Full Text] [Related]
14. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety of antipsychotics: another look at the risk of diabetes.
Moisan J; Turgeon M; Desjardins O; Grégoire JP
Can J Psychiatry; 2013 Apr; 58(4):218-24. PubMed ID: 23547645
[TBL] [Abstract][Full Text] [Related]
19. Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.
Chou PH; Chu CS; Lin CH; Cheng C; Chen YH; Lan TH; Huang MW
Schizophr Res; 2016 Jul; 174(1-3):137-143. PubMed ID: 27061658
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.
Koro CE; Fedder DO; L'Italien GJ; Weiss S; Magder LS; Kreyenbuhl J; Revicki D; Buchanan RW
Arch Gen Psychiatry; 2002 Nov; 59(11):1021-6. PubMed ID: 12418935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
